ArticleJournal of ultrasound2026
Microwave ablation therapy of an intrathyroid parathyroid adenoma.
Article in Journal of ultrasound, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPrimary Hyperparathyroidism (PHPT) is a disorder of calcium metabolism most frequently due to a parathyroid adenoma. Although parathyroidectomy is the treatment of choice, Microwave Ablation Therapy (MWA) has also been applied for the treatment of PHPT. The incidence of ectopic parathyroid glands ranges from 10 to 22% with an intrathyroid parathyroid adenoma (IPA) being a possible cause of PHPT (0.7-6.7%). The best treatment for IPAs is still in debate. CASE REPORT: A 47-year-old woman was referred to the endocrinology clinic following an incidental finding of PHPT. The patient had no personal history of bone fractures or nephrolithiasis. Biochemical analysis demonstrated elevated serum calcium (11.9 mg/dL), low serum phosphate (2 mg/dL), and elevated parathyroid hormone (PTH) levels (199 pg/mL). A [99mTc]Tc-MIBI scintigraphy scan showed slight persistent uptake in the inferior third of the left thyroid lobe and the neck ultrasound identified a mixed predominantly solid and slightly hypoechoic nodule, measuring 2.1 × 1.8 × 1.5 cm (LxTxAP). Fine-needle aspiration biopsy (FNAB) confirmed IPA. MWA of the IPA in the left thyroid lobe was performed with no complications and a 90% nodule volume reduction and a reduction of serum calcium and PTH values at 6 months were achieved, no longer reaching surgical criteria. DISCUSSION AND
conclusionTo our knowledge this is the first reported MWA of an IPA. Literature review identified a total of 5 patients that had IPAs treated with radiofrequency ablation. MWA ablation may be a viable alternative to surgery in the treatment of IPAs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.